International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 5 of the 68 sources its claims cite were checked for support.
Abstract
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregnancy Study Groups (IADPSG) Consensus Panel recommendations (3) for the diagnosis of gestational diabetes mellitus (GDM) to that cohort. The Brazilian study provided evidence that adverse perinatal outcomes are associated with levels of maternal glycemia below those diagnostic of GDM by American Diabetes Association or World Health Organization criteria. However, the results were potentially confounded by the treatment of GDM. It did find that women with GDM were at increased risk for some …
Overview
CoChat Summary
## TL;DR
This IADPSG consensus report recommends new gestational diabetes mellitus (GDM) diagnostic thresholds based on HAPO study data, using a 75-g OGTT and outcome-linked glucose cutoffs. It also recommends early detection of overt diabetes in pregnancy and notes that these recommendations will increase the frequency of diagnosed hyperglycemic disorders in pregnancy.
## Key findings
- In the HAPO study, a 75-g OGTT was performed in a heterogeneous, multinational, multicultural, ethnically diverse cohort of approximately 25,000 women in the third trimester; medical caregivers were blinded unless predefined glucose criteria were exceeded.
- The report states that the HAPO data showed continuous, graded associations between maternal glucose and primary outcomes, with no obvious thresholds; associations were also observed for secondary outcomes and did not differ among centers.
- The recommended diagnostic thresholds correspond to glucose levels where odds for birth weight >90th percentile, cord C-peptide >90th percentile, and percent body fat >90th percentile reached 1.75 times the estimated odds at mean glucose values; by these criteria, FPG alone identified 8.3% of the HAPO cohort, FPG plus 1-hour glucose identified an additional 5.7%, and 2-hour glucose another 2.1%, for a total GDM incidence of 17.8%.
- Among the HAPO cohort, 11.1% had only one elevated result, 3.9% had two elevated results, 1.1% had all three elevated, and 1.7% were unblinded because FPG or 2-hour glucose exceeded 5.8 mmol/l (105 mg/dl) or 11.1 mmol/l (200 mg/dl).
## Methods
- Consensus report based on review of the HAPO study, additional unpublished HAPO findings, and other published studies discussed at a June 2008 IADPSG workshop/meeting in Pasadena, followed by consensus panel deliberation.
- HAPO design described as observational: a 75-g OGTT in a large multinational cohort, with blinded caregivers except for preset safety thresholds.
- Thresholds were derived from fully adjusted logistic regression models relating continuous maternal glucose measures (FPG, 1-hour, 2-hour) to outcomes; the panel selected an odds ratio threshold of 1.75 relative to mean glucose values.
## Limitations
- The paper states that recommendations for detecting overt diabetes during pregnancy are based on the opinions of the IADPSG Consensus Panel because prospective studies or appropriately designed clinical trials were not available.
- It states that it was not determined whether universal early testing for overt diabetes is clinically valuable or cost-effective.
- Evident from the text: the HAPO study was observational, not a clinical trial, so the diagnostic thresholds are inferred from associations rather than randomized intervention effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 36 Not checked · 22 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Similar associations were also observed for secondary outcomes (25,26).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
The Abstract of our copy states that the predefined primary outcomes (size at birth, cesarean delivery, neonatal hypoglycemia, fetal hyperinsulinemia) were reported elsewhere, and that this report's goals were to examine maternal glycemia against additional/newborn anthropometric outcomes (sum of skin folds, individual skin folds, percent body fat) plus cord C-peptide. The Results report strong, graded, continuous associations for these outcomes (e.g., ORs 1.33–1.47 for percent body fat >90th percentile and 1.28–1.56 for individual skin folds), and the Discussion explicitly says 'This pattern is similar to that reported for maternal glucose and birth weight >90th percentile.' That covers the claim's substance — similar associations for the secondary/additional outcomes — even though the paper does not use the label 'secondary outcomes'. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Associations of LGA and excess adiposity with fetal hyperinsulinemia are strong and independent of confounders (26,37,38).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
What the sources say
- Supportedcites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 source
In the Results (Table 5), higher cord C-peptide, the paper’s measure of fetal insulin, is strongly associated with birth weight above the 90th percentile and adiposity measures. The Discussion states that the relationships persisted after adjustment for potential confounders. The paper does not claim that every possible confounder was excluded. (LLM, conf=0.92)
- Not checked yetcites [37] Metzger BE Silverman BL Freinkel N Dooley SL Ogata ES Green OC: Amniotic fluid insulin concentration as a predictor of obesity. Arch Dis Child 1990; 65: 1050– 1052 2241225 PMC1590256 source
- Not checked yetcites [38] Weiss PA Haeusler M Tamussino K Haas J: Can glucose tolerance test predict fetal hyperinsulinism? BJOG 2000; 107: 1480– 1485 11192103 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although not directly comparable, it was concluded that results of the two randomized controlled trials (47,48) and HAPO (25,26) are highly complementary.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM > Other considerations
What the sources say
- Supportedcites [47] Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 15951574 source
The paper identifies itself as a randomized clinical trial and reports its treatment results (secondary outcomes; page unavailable). In the citing sentence, this citation identifies one of the two trials whose results are being discussed; it does not attribute the cross-study judgment of complementarity to this trial paper. (LLM, conf=0.88)
- Not checked yetcites [48] Landon MB Spong CY Thom E Carpenter MW Ramin SM Casey B Wapner RJ Varner MW Rouse DJ Thorp JM Jr Sciscione A Catalano P Harper M Saade G Lain KY Sorokin Y Peaceman AM Tolosa JE Anderson GB: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009: 361; 1339– 1348. PMC2804874 19797280
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
- Could not verifycites [26] HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 2009; 58: 453– 459 19011170 PMC2628620 sourceExperimental — accuracy not yet measured
The Abstract reports HAPO findings on maternal glucose and pregnancy outcomes, but does not compare them with randomized trials. Searches for randomized trials and for the claimed complementarity found no passage in our copy making that comparison. No page numbers were available. (LLM, conf=0.70)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Importantly, there were continuous graded relationships between higher maternal glucose and increasing frequency of the primary outcomes, independent of other risk factors (25).”
- Also stated in: § Future considerations · boosted
“The HAPO study was a basic epidemiological investigation that for the first time conclusively identified strong continuous associations of maternal glucose levels below those diagnostic of diabetes with several perinatal outcomes.”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > THE HAPO STUDY
What the sources say
- Not checked yetcites [25] HAPO Study Cooperative Research Group Metzger BE Lowe LP Dyer AR Trimble ER Chaovarindr U Coustan DR Hadden DR McCance DR Hod M McIntyre HD Oats JJ Persson B Rogers MS Sacks DA: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991– 2002 18463375 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Future considerations · boosted
None of the sources cited for this claim have been checked yet.
In the paper
“HAPO data show strong linear associations of risks for >90th percentiles of birth weight, cord C-peptide, and percent body fat with each of three measures of maternal glucose (FPG, 1-h, and 2-h post–75-g load).”
§ International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy > TRANSLATION OF HAPO STUDY RESULTS FOR DIAGNOSIS OF GDM
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 62 claims and to verify the 63 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GDM was identified when fasting blood glucose (FBG) ≥ 5.1 mmol/L during the first trimester or any plasma glucose after a 75 g OGTT performed as: FBG ≥ 5.1 mmol/L, 1 h after glucose load ≥ 10.0 mmol/L or 2 h after glucose load ≥ 8.5 mmol/L using the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) [28].”
From Associations of maternal pre-pregnancy BMI and gestational weight gain with the risks of adverse pregnancy outcomes in Chinese women with gestational diabetes mellitus (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“to adopt diagnostic glucose thresholds corresponding to a HAPO OR of 1.75 (fasting plasma glucose [FPG] 5.1–6.9 mmol/L, one‐hour plasma glucose [1hPG] ≥ 10.0 mmol/L, and/or two‐hour plasma glucose [2hPG] 8.5–11.0 mmol/L). 14”
From Australasian Diabetes in Pregnancy Society ( ADIPS ) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The IADPSG diagnostic thresholds are the first criteria based on risks of adverse perinatal outcomes, rather than risk of subsequent development of maternal diabetes1 or by applying thresholds that define impaired glucose tolerance outside of pregnancy.5,6”
From Gestational Diabetes Mellitus (2019) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“following the diagnostic criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (18)”
From Diabetes gestacional y riesgo de apnea obstructiva del sueño en el tercer trimestre (2025) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Based on the HAPO Study and other studies, new criteria for the diagnosis of gestational diabetes were proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) 2 and adopted by the World Health Organization and others.3,4”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [2]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303 · cited 2×
“Long-term risks associated with fetal macrosomia in infants of women with GDM (independent of confounders) include childhood overweight (43,44) and metabolic factors that may increase risk of cardiovascular disease (CVD) (45).”
BackgroundA Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
(1964) · PubMed · Cited by 1,230
Research works printed but not linked: 2
- Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Health Canada 1994; 15– 23
- National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London, U.K., RCOG Press, 2008 21370515
Cited by
Items 401–500 of 1,132
Controversies in gestational diabetes
Nolan, C. J. (2010) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2010.10.004 · Cited by 96
Hashimoto, K., & Koga, M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i8.1045 · Cited by 92
Wexler, D. J., Powe, C. E., Barbour, L. A., Buchanan, T., Coustan, D. R., Corcoy, R., Damm, P., Dunne, F., Feig, D. S., Ferrara, A., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002726 · Cited by 80
Barnes, R. A., Wong, T., Ross, G. P., Griffiths, M. M., Smart, C. E., Collins, C. E., MacDonald-Wicks, L., & Flack, J. R. (2020) · Diabetes Care · doi:10.2337/dc19-0800 · Cited by 80
Flynn, A. C., Seed, P. T., Patel, N., Barr, S., Bell, R., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng‐Ntim, E., Robinson, S. M., et al. (2016) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0450-2 · Cited by 89
“Whilst, insulin resistance is higher in obese women at the beginning of pregnancy [52], only 25% develop GDM according to IADPSG criteria [17].”
MethodInfluentialWhite, S. L., Lawlor, D. A., Briley, A. L., Godfrey, K. M., Nelson, S. M., Oteng-Ntim, E., Robson, S. C., Sattar, N., Seed, P. T., Vieira, M. C., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167846 · Cited by 80
Macaulay, S., Ngobeni, M., Dunger, D. B., & Norris, S. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.012 · Cited by 92
Yang, G.-R., Dye, T., & Li, D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107811 · Cited by 85
Maternal obesity influences birth weight more than gestational diabetes
Alfadhli, E. M. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03571-5 · Cited by 89
Owens, L. A., Sedar, J., Carmody, L., & Dunne, F. (2015) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-015-0499-y · Cited by 76
Promoting Health After Gestational Diabetes: A National Diabetes Education Program Call to Action
Gabbe, S. G., Landon, M. B., Warren-Boulton, E., & Fradkin, J. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182393208 · Cited by 79
Glycosylated Fibronectin as a First-Trimester Biomarker for Prediction of Gestational Diabetes
Rasanen, J. P., Snyder, C. K., Rao, P. V., Mihalache, R., Heinonen, S., Gravett, M. G., Roberts, C. T., & Nagalla, S. R. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182a0c88b · Cited by 78
Recommended changes to diagnostic criteria for gestational diabetes: Impact on workload
FLACK, J. R., ROSS, G. P., HO, S., & McELDUFF, A. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01218.x · Cited by 78
Mazumder, T., Akter, E., Rahman, S. M., Islam, M. T., & Talukder, M. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052583 · Cited by 79
Wilson, R. L., Bianco‐Miotto, T., Leemaqz, S., Grzeskowiak, L. E., Dekker, G., & Roberts, C. T. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.11.016 · Cited by 82
A Review of the Pathophysiology and Management of Diabetes in Pregnancy
Egan, A. M., Dow, M. L., & Vella, A. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.02.019 · Cited by 67
Defining Heterogeneity Among Women With Gestational Diabetes Mellitus
Powe, C. E., Hivert, M.-F., & Udler, M. S. (2020) · Diabetes · doi:10.2337/dbi20-0004 · Cited by 75
Macrosomia and large for gestational age in Asia: One size does not fit all
Harvey, L., van Elburg, R. M., & van der Beek, E. M. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14787 · Cited by 88
Weight gain during pregnancy: A narrative review on the recent evidences
Dalfrà, M. G., Burlina, S., & Lapolla, A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109913 · Cited by 95
The Placental Role in Gestational Diabetes Mellitus: A Molecular Perspective
Calvo, M. C. C., Parra, H., Santeliz, R., Bautista, J., Luzardo, E., Villasmil, N., Martínez, M. S., Chacín, M., Cano, C., Checa-Ros, A., et al. (2024) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2024.20.1.5 · Cited by 102
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Chamberlain, C., McNamara, B., Williams, E. D., Yore, D., Oldenburg, B., Oats, J., & Eades, S. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2389 · Cited by 72
Noctor, E., Crowe, C., Carmody, L. A., Kirwan, B., O’Dea, A., Glynn, L. G., McGuire, B. E., O’Shea, P. M., & Dunne, F. P. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0621-z · Cited by 79
“Their recommendations included lowering the fasting and 1-h thresholds for GDM diagnosis [10], and also allowing a diagnosis to be made on the basis of a single abnormal value (rather than the two abnormal values required in the NDDG and Carpenter–Coustan criteria).”
BackgroundKollmann, M., Klaritsch, P., Martins, W. P., Guenther, F., Schneider, V., Herzog, S. A., Craciunas, L., Lang, U., Obermayer-Pietsch, B., Lerchbaum, E., et al. (2015) · Human Reproduction · doi:10.1093/humrep/dev187 · Cited by 77
“8 mmol/l (Metzger et al., 2010).”
Souza, L. R. D., Berger, H. M., Retnakaran, R. R., Vlachou, P. A., Maguire, J. L., Nathens, A. B., Connelly, P. W., & Ray, J. G. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.43 · Cited by 83
Barthow, C. A., Wickens, K. L., Stanley, T., Mitchell, E. A., Maude, R., Abels, P., Purdie, G., Murphy, R., STONE, P. R., Kang, J., et al. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0923-y · Cited by 88
Sklempe Kokic, I., Ivanisevic, M., Biolo, G., Simunic, B., Kokic, T., & Pisot, R. (2018) · Women and Birth · doi:10.1016/j.wombi.2017.10.004 · Cited by 74
Wang, H., Yang, J., Du, H., Xu, L., Liu, S., Yi, J., Qian, X., Chen, Y., Jiang, Q., & He, G. (2018) · Environment International · doi:10.1016/j.envint.2018.01.027 · Cited by 84
Pheiffer, C., Dias, S. C., Rheeder, P., & Adam, S. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0325-0 · Cited by 87
Davis, E. M., Abebe, K. Z., Simhan, H. N., Catalano, P., Costacou, T., Comer, D., Orris, S., Ly, K., Decker, A., Mendez, D., et al. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004431 · Cited by 78
Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study
Auvinen, A.-M., Luiro, K., Jokelainen, J. J., Järvelä, I. Y., Knip, M., AUVINEN, J. P., & Tapanainen, J. S. (2020) · Diabetologia · doi:10.1007/s00125-020-05215-3 · Cited by 78
Belsti, Y., Moran, L., Du, L., Mousa, A., Silva, K. D., Enticott, J., & Teede, H. J. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105228 · Cited by 83
Gradmark, A., Pomeroy, J., Renström, F., Steiginga, S., Persson, M., Wright, A., Bluck, L., Domellöf, M., Kahn, S. E., Mogren, I., et al. (2011) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-11-44 · Cited by 76
“A standard 75 g oral glucose tolerance test (OGTT) [19] was performed with venous blood samples drawn prior to the challenge and at 30, 60 and 120 minutes after the glucose load.”
MethodGlycemic Index and Pregnancy: A Systematic Literature Review
Louie, J. C. Y., Brand-Miller, J. C., Markovic, T. P., Ross, G. P., & Moses, R. G. (2010) · Journal of Nutrition and Metabolism · doi:10.1155/2010/282464 · Cited by 74
Nankervis, A. J., McIntyre, D. H., Moses, R. G., Gp, R., Callaway, L. K., Porter, C., Jeffries, W. S., & Boorman, C. (2014) · Cited by 159
Persistent organic pollutants in early pregnancy and risk of gestational diabetes mellitus
Vafeiadi, M., Roumeliotaki, T., Chalkiadaki, G., Rantakokko, P., Kiviranta, H., Fthenou, E., Kyrtopoulos, S. Α., Kogevinas, M., & Chatzi, L. (2016) · Environment International · doi:10.1016/j.envint.2016.10.005 · Cited by 80
Poirier, C., Desgagné, V., Guérin, R., & Bouchard, L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0856-5 · Cited by 88
Voaklander, B., Rowe, S., Sanni, O., Campbell, S., Eurich, D., & Ospina, M. B. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30046-2 · Cited by 72
Genetic and inflammatory factors underlying gestational diabetes mellitus: a review
Ray, G. W., Zeng, Q., Kusi, P., Zhang, H., Shao, T., Yang, T., Wei, Y., Li, M., Che, X., & Guo, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399694 · Cited by 87
Obesity and Diabetes in Mothers and Their Children: Can We Stop the Intergenerational Cycle?
Herring, S. J., & Oken, E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-010-0156-9 · Cited by 73
Collier, A., Abraham, E. C., Armstrong, J., Godwin, J., Monteath, K., & Lindsay, R. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12552 · Cited by 77
Liu, H., Li, J., Leng, J., Wang, H., Liu, J., Li, W., Liu, H., Wang, S., Ma, J., Chan, J. C. N., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3397 · Cited by 81
Probiotics for preventing gestational diabetes
Davidson, S. J., Barrett, H. L., Price, S. A., Callaway, L. K., & Dekker Nitert, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009951.pub3 · Cited by 76
Fisher, B. G., Frederiksen, H., Andersson, A.-M., Juul, A., Thankamony, A., Ong, K. K., Dunger, D. B., Hughes, I. A., & Acerini, C. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00099 · Cited by 78
Liu, P. J., Liu, Y.-P., Ma, L., Yao, A. M., Chen, X. Y., Hou, Y. X., Wu, L., & Xia, L. Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s251846 · Cited by 77
“5 mmol/L.(31) After delivery, all the related data were sourced from medical records.”
MethodOzgu-Erdinc, A. S., Yilmaz, S., Yeral, M. I., Seckin, K. D., Erkaya, S., & Danisman, A. N. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.973397 · Cited by 73
“The cut-off value for FPG was 90 mg/dL within the normal range but very close to the IADPSG criteria of 92 mg/dL as a GDM diagnosis in the first antenatal visit [38].”
BackgroundMackillop, L., Loerup, L., Bartlett, K., Farmer, A., Gibson, O. J., Hirst, J. E., Kenworthy, Y., Kevat, D. A., Levy, J. C., & Tarassenko, L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814542271 · Cited by 75
Collaborators, S. S., Pintaudi, B., Fresa, R., Dalfrà, M., Dodesini, A. R., Vitacolonna, E., Tumminia, A., Sciacca, L., Lencioni, C., Marcone, T., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1208-x · Cited by 82
“This is in line with the results of the HAPO study [19, 20] and was also documented by another study in which a regression tree analysis was performed [25].”
MethodResultSleep duration and quality, and risk of gestational diabetes mellitus in pregnant Chinese women
Wang, H., Leng, J., Li, W., Wang, L., Zhang, C., Li, W., Liu, H., Zhang, S., Chan, J., Hu, G., et al. (2017) · Diabetic Medicine · doi:10.1111/dme.13155 · Cited by 75
Bhavadharini, B., Uma, R., Saravanan, P., & Mohan, V. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0031-y · Cited by 75
Sun, Y., Juan, J., Xu, Q., Su, R., Hirst, J. E., & Yang, H. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13013 · Cited by 83
“GDM was diagnosed using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria by 75-g oral glucose tolerance test (OGTT) between 24-28 weeks of gestation.(9) After diagnosis, all women with GDM were referred to a GDM oneday care clinic for education on GDM, diet, and physical activity…”
MethodCardiac changes in infants of diabetic mothers
Al‐Beltagi, M., Razaky, O. E., & Amrousy, D. M. E. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i8.1233 · Cited by 85
Lovati, E., Beneventi, F., Simonetta, M., Laneri, M., Quarleri, L., Scudeller, L., Albonico, G., Locatelli, E., Cavagnoli, C., Tinelli, C., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.002 · Cited by 85
Metabolic complications of obesity
Pedersen, S. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.004 · Cited by 88
The treatment of booking gestational diabetes mellitus (TOBOGM) pilot randomised controlled trial
Simmons, D., Nema, J., Parton, C., Vizza, L., Robertson, A., Rajagopal, R., Ussher, J., & Perz, J. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1809-y · Cited by 71
Gestational Diabetes and T-cell (Th1/Th2/Th17/Treg) Immune Profile
SIFNAIOS, E., MASTORAKOS, G., PSARRA, K., PANAGOPOULOS, N.-D., PANOULIS, K., VITORATOS, N., RIZOS, D., & CREATSAS, G. (2019) · In Vivo · doi:10.21873/invivo.11435 · Cited by 75
PFOS, PFOA, estrogen homeostasis, and birth size in Chinese infants
Wang, H., Du, H., Yang, J., Jiang, H., O, K., Xu, L., Liu, S., Yi, J., Qian, X., Chen, Y., et al. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.01.061 · Cited by 75
Vitagliano, A., Saccone, G., Cosmi, E., Visentin, S., Dessole, F., Ambrosini, G., & Berghella, V. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-5005-0 · Cited by 74
Asgharian, H., Rad, A. H., Mirghafourvand, M., & Mohammad‐Alizadeh‐Charandabi, S. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01900-1 · Cited by 81
Bhowmik, B., Siddiquee, T., Majumder, A., Mdala, I., Hossain, I. A., Hassan, Z., Jahan, I., Moreira, N. C. D. V., Alim, A. M., Basit, A., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2571-5 · Cited by 87
Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes
Trujillo, J., Vigo, Á., Reichelt, A. J., Duncan, B. B., & Schmidt, M. I. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.06.001 · Cited by 105
“5 mmol/l) [1].”
BackgroundInfluentialChong, Y.-S., Cai, S., Lin, H., Soh, S. E., Lee, Y.-S., Leow, M. K.-S., Chan, Y.-H., Chen, L., Holbrook, J. D., Tan, K.-H., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-345 · Cited by 74
“American Diabetes Association, American College of Obstetricians and Gynecologists, UK National Institute for Health and Clinical Excellence (NICE) recommend screening in women with known risk factors [15-17] while other organizations like International Association of Diabetes and Pregnancy Study Groups (IADPSG) suppo…”
BackgroundPrevalence of gestational diabetes mellitus in urban and rural Tanzania
Mwanri, A. W., Kinabo, J., Ramaiya, K. L., & Feskens, E. J. M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.021 · Cited by 86
Benhalima, K., Hanssens, M., Devlieger, R., Verhaeghe, J., & Mathieu, C. (2013) · International Journal of Endocrinology · doi:10.1155/2013/248121 · Cited by 73
Lacroix, M., Battista, M., Doyon, M., Moreau, J., Patenaude, J., Guillemette, L., Ménard, J., Ardilouze, J., Perron, P., & Hivert, M. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0842-y · Cited by 78
“At 2 trimester (23–30 weeks), all women performed a 75g oral glucose tolerance test (OGTT) under fasting state for routine GDM diagnosis based on International Association of Diabetes and Pregnancy Study Groups criteria [26].”
MethodGhomian, N., Vahed, S. H. M., Firouz, S., Yaghoubi, M. A., Mohebbi, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27238 · Cited by 77
Wang, Y., Yan, P., Fu, T., Yuan, J., Yang, G., Liu, Y., & Zhang, Z.-J. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.02.003 · Cited by 80
Pathirana, M. M., Lassi, Z. S., Alì, A., Arstall, M. A., Roberts, C. T., & Andraweera, P. H. (2020) · Endocrine · doi:10.1007/s12020-020-02492-1 · Cited by 84
Shang, M., Zhao, J., Yang, L., & Lin, L. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.010 · Cited by 76
“Recently, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommended a more lenient diagnostic criteria in 2010 [14,15] mainly based on the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study [2].”
BackgroundMethodReduced Fetal Telomere Length in Gestational Diabetes
Xu, J., Ye, J., Wu, Y., Zhang, H., Luo, Q., Han, C., Ye, X., Wang, H., He, J., Huang, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086161 · Cited by 70
“GDM was diagnosed according to the criteria recommended by International Association of Diabetes and Pregnancy Study Groups (IADPSG) [16], and gestational hypertension and preeclampsia were diagnosed and classified according to the criteria recommended by American college of Obstetrics and Gynecology (ACOG) [17].”
MethodGestational diabetes guidelines in a HAPO world
Leary, J., Pettitt, D. J., & Jovanovič, L. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.05.009 · Cited by 92
Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age
Dietl, A., Cupisti, S., Beckmann, M., Schwab, M., & Zollner, U. (2015) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0035-1546109 · Cited by 73
Leitner, M., Fragner, L., Danner, S., Holeschofsky, N., Leitner, K., Tischler, S., Doerfler, H., Bachmann, G., Sun, X., Jaeger, W., et al. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00084 · Cited by 71
“GDM was diagnosed with a standard 2 h 75 g oral glucose tolerance test (oGTT), according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria (International Association of Pregnancy Study Groups Consensus Panel et al., 2010; Colagiuri et al., 2014).”
MethodBenhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3615-7 · Cited by 72
Larrabure-Torrealva, G. T., Martinez, S., Luque-Fernandez, M. A., Sanchez, S. E., Mascaro, P. A., Ingar, H., Castillo, W., Zumaeta, R., Grande, M., Motta, V., et al. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1904-0 · Cited by 72
Epigenetic Changes in Gestational Diabetes Mellitus
Dłuski, D. F., Wolińska, E., & Skrzypczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147649 · Cited by 80
Wang, D., Xu, S., Chen, H., Zhong, L., & Wang, Z. (2015) · Clinical Endocrinology · doi:10.1111/cen.12742 · Cited by 78
Yang, X., Tian, H., Zhang, F., Zhang, C., Li, Y., Leng, J., Wang, L., Liu, G., Dong, L., Yu, Z., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0290-2 · Cited by 71
“This study tested that lifestyle modification implemented in a shared care (SC) system among care providers was able to reduce adverse pregnancy outcomes as compared to usual care among women with GDM diagnosed by the IADPSG’s criteria [13]; and evaluated the feasibility of utilizing the 3-tier care delivery to provid…”
BackgroundAgarwal, M., Dhatt, G. S., & Othman, Y. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.03.006 · Cited by 83
Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS
Liu, T., Li, J., Xu, F., Wang, M., Ding, S., Xu, H., & Dong, F. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9211-3 · Cited by 83
Physical activity patterns and gestational diabetes outcomes – The wings project
Anjana, R. M., Sudha, V., Lakshmipriya, N., Anitha, C., Unnikrishnan, R., Bhavadharini, B., Mahalakshmi, M. M., Maheswari, K., Kayal, A., Ram, U., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.041 · Cited by 66
Mortier, I., Blanc, J., Tosello, B., Gire, C., Bretelle, F., & Carcopino, X. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4505-7 · Cited by 80
Bardenheier, B. H., Elixhauser, A., Imperatore, G., Devlin, H. M., Kuklina, E. V., Geiss, L. S., & Correa, A. (2013) · Diabetes Care · doi:10.2337/dc12-0901 · Cited by 71
Potter, J. M., Hickman, P. E., Oakman, C., Woods, C., & Nolan, C. J. (2020) · Diabetes Care · doi:10.2337/dc20-0304 · Cited by 71
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy
Dickens, L. T., & Thomas, C. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1147-0 · Cited by 84
Ye, Z., Wang, S., Huang, X., Chen, P., Deng, L., Li, S., Lin, S., Wang, Z., & Liu, B. (2022) · Diabetes · doi:10.2337/db21-0909 · Cited by 77
Modeling the Independent Effects of Gestational Diabetes Mellitus on Maternity Care and Costs
Gillespie, P., Cullinan, J., O’Neill, C., Dunne, F., & Collaborators, F. T. A. D. (2013) · Diabetes Care · doi:10.2337/dc12-0461 · Cited by 69
Changing trends in management of gestational diabetes mellitus
Poomalar, G. K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.284 · Cited by 68
Rauh, K., Kunath, J., Rosenfeld, E., Kick, L., Ulm, K., & Hauner, H. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-119 · Cited by 69
“Tests are performed by the participating gynaecological practices according to the 2011 guidelines of the German Diabetes Society (DDG) and the German Society of Gynaecology and Obstetrics (DGGG) [54] which is in line with the guidelines of the International Association of the Diabetes and Pregnancy Study Groups (IADP…”
MethodSachse, D., Sletner, L., Mørkrid, K., Jenum, A. K., Birkeland, K. I., Rise, F., Piehler, A. P., & Berg, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052399 · Cited by 80
“[18,19] Therefore, finding substances (or patterns thereof) non-invasively in the urine profiles that could predict the development of GDM before it manifests itself would provide a highly desirable improvement, and the relatively young discipline of metabolomics claims this to be its strength.”
BackgroundBhavadharini, B., Mahalakshmi, M. M., Anjana, R. M., Maheswari, K., Uma, R., Deepa, M., Unnikrishnan, R., Ranjani, H., Pastakia, S. D., Kayal, A., et al. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0028-6 · Cited by 69
Cord Metabolic Profiles in Obese Pregnant Women: Insights Into Offspring Growth and Body Composition
Patel, N., Hellmuth, C., Uhl, O., Godfrey, K. M., Briley, A. L., Welsh, P. I., Pasupathy, D., Seed, P. T., Koletzko, B. V., & Poston, L. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00876 · Cited by 74
Maternal and neonatal outcome in mothers with gestational diabetes mellitus
Shamanna, S. B., Prakash, G., Das, A., Habeebullah, S., & Bhat, V. B. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_66_17 · Cited by 72
Liao, J., Chen, X., Xu, S., Li, Y., Zhang, B., Cao, Z., Zhang, Y., Liang, S., Hu, K., & Xia, W. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108526 · Cited by 68
Diagnosis of Gestational Diabetes
Coustan, D. R., & Carpenter, M. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_2 · Cited by 72
Chirakalwasan, N., Amnakkittikul, S., Wanitcharoenkul, E., Charoensri, S., Saetung, S., Chanprasertyothin, S., Chailurkit, L., Panburana, P., Bumrungphuet, S., Thakkinstian, A., et al. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6972 · Cited by 72
“…criteria for the screening step were diet-controlled GDM (diagnosed using The International Association of the Diabetes and Pregnancy Study Groups 19 ), singleton pregnancy, gestational age (GA) between 24 and 34 weeks, and prepregnancy body mass index (BMI) ≥ 25 kg/ m 2 (obese per Asian…”
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options
Mirabelli, M., CHIEFARI, E. D., Tocci, V., Greco, E. A., FOTI, D. P., & Brunetti, A. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.06.003 · Cited by 75
Mu, J., Guo, X., Zhou, Y., & Cao, G. (2023) · Nutrients · doi:10.3390/nu15061375 · Cited by 80
Gestational diabetes mellitus, hypertension, and dyslipidemia as the risk factors of preeclampsia
Aziz, F., Khan, M. F., & Moiz, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-56790-z · Cited by 82
“The International Association of Diabetes and Pregnancy Study Groups (IADPSG) has formed the diagnostic criteria for GDM based on the findings of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study 3 .”
MethodFirst‐trimester glycosylated hemoglobin in women at high risk for gestational diabetes
Amylidi, S., Mosimann, B., Stettler, C., Fiedler, G. M., Surbek, D., & Raio, L. (2016) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12784 · Cited by 67
Metadata
- Authors
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Corresponding author
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-03-01
- Volume
- 33
- Issue
- 3
- Pages
- 676-682
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2827530
- OpenAlex
- W2616235706
- Cited by
- 5,390
- References
- 56
- Citations by year
- 2026: 314 · 2025: 377 · 2024: 446 · 2023: 423 · 2022: 494 · 2021: 507 · 2020: 425 · 2019: 350 · 2018: 367 · 2017: 297 · 2016: 274 · 2015: 296 · 2014: 235 · 2013: 203 · 2012: 167
- FWCI
- 250.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- American Diabetes Association
- Kaiser Permanente
- National Institute of Child Health and Human Development (R01‐HD34242, R01-HD-34243)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD-34243, R01-HD-34242, R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, IADPSG criteria, perinatal outcomes, maternal glycemia, diagnostic thresholds
- MeSH terms
- Female, Health Planning Guidelines, Humans, Hyperglycemia, International Cooperation, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Societies, Medical, Diabetes, Gestational, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.